{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:13:31Z","timestamp":1761909211099,"version":"build-2065373602"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00280-025-04826-0","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:20:33Z","timestamp":1761582033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombosis and cancer what do the recommandations say"],"prefix":"10.1007","volume":"95","author":[{"given":"Sihame","family":"Lkhoyaali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumaima","family":"Lamsyah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roda Hassan","family":"Eltigani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wydad","family":"Nadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saber","family":"Boutayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"4826_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jmv.2013.03.001","volume":"38","author":"R Belhadj Chaidi","year":"2013","unstructured":"Belhadj Chaidi R (2013) Application des recommandations Dans Le traitement de La maladie thromboembolique Veineuse Chez Les patients Atteints de cancer: \u00e9tude r\u00e9trospective Sur 145 Cas. J Mal Vasc 38:185\u2013192","journal-title":"J Mal Vasc"},{"key":"4826_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archinte.166.4.458","volume":"166","author":"HK Chew","year":"2006","unstructured":"Chew HK, Wun T, Harvey D, Zhou H, White RH (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166:458\u2013464","journal-title":"Arch Intern Med"},{"key":"4826_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.bjc.6601964","volume":"91","author":"JT Murchison","year":"2004","unstructured":"Murchison JT, Wylie L, Stockton DL (2004) Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer 91:92\u201395","journal-title":"Br J Cancer"},{"key":"4826_CR4","doi-asserted-by":"crossref","unstructured":"S.KADDOURI, Z.CHAHBI, et al. Thrombosis and cancer: case series of 25 patients. Am J Intern Med, (2017) 5, 4, p. 61\u201366","DOI":"10.11648\/j.ajim.20170504.13"},{"key":"4826_CR5","unstructured":"D.MALKA NGIRAR et al (2022) Prophylaxis and management of cancer-associated thrombosis: practical issues about anticoagulant use. Bull Cancer, p. S0007\u20134551 (22) 00424"},{"key":"4826_CR6","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902\u20134907","journal-title":"Blood"},{"key":"4826_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-0040-1708481","volume":"120","author":"A Abdulla","year":"2020","unstructured":"Abdulla A, Davis WM, Ratnaweera N, Szefer E, Ballantyne Scott B, Lee AYY (2020) A Meta-Analysis of case fatality rates of recurrent venous thromboembolism and major bleeding in patients with cancer. Thromb Haemost 120:702\u2013713","journal-title":"Thromb Haemost"},{"key":"4826_CR8","unstructured":"MAZZOLAI L et, ALATRI, Adriano (2023) Treatment of cancer-associated venous thromboembolism. Eur Soc Cardiol"},{"key":"4826_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.amjmed.2016.10.017","volume":"130","author":"I Mahe","year":"2017","unstructured":"Mahe I, Chidiac J, Bertoletti L, Font C, Trujillo-Santos J, Peris M, Perez Ductor C, Nieto S, Grandone E, Monreal M (2017) RIETE investigators. The clinical course of venous thromboembolism May differ according to cancer site. Am J Med 130:337\u2013347","journal-title":"Am J Med"},{"key":"4826_CR10","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S0049-3848(16)30092-5","volume":"140","author":"S Eichinger","year":"2016","unstructured":"Eichinger S (2016) Cancer associated thrombosis: risk factors and outcomes. Thromb Res 140:S12\u2013S17 [CrossRef] [PubMed]","journal-title":"Thromb Res"},{"key":"4826_CR11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/annonc\/mdm284","volume":"18","author":"M Mandal \u00afa","year":"2007","unstructured":"Mandal \u00afa M, Reni M, Cascinu S, Barni S, Florani I, Cereda S, Berardi R, Mosconi S, Torri V, Labianca R (2007) Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol 18:1660\u20131665","journal-title":"Ann Oncol"},{"key":"4826_CR12","doi-asserted-by":"publisher","first-page":"117955492312202","DOI":"10.1177\/11795549231220297","volume":"17","author":"D Pavlovic","year":"2023","unstructured":"Pavlovic D, Niciforovic D, Markovic M, Papic D (2023) Cancer-Associated thrombosis: Epidemiology, pathophysiological Mechanisms, Treatment, and risk assessment. Clin Med Insights Oncol 17:1179554923122029","journal-title":"Clin Med Insights Oncol"},{"key":"4826_CR13","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv \u00afath-Puh\u1ed9 E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, Ay C, B\u00fcller HR, S\u00f8rensen H (2021) T.Venous thromboembolism in cancer patients: A population-based cohort study. Blood 137:1959\u20131969","journal-title":"Blood"},{"key":"4826_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","volume":"243","author":"G Agnelli","year":"2006","unstructured":"Agnelli G, Bolis G, Capussoti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the \u00aeRISTOS project. Ann Surg 243:89\u201395","journal-title":"Ann Surg"},{"key":"4826_CR15","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","volume":"49","author":"AJ Walker","year":"2013","unstructured":"Walker AJ, Card TR, West J, Crooks C, Grainge MJ (2013) Incidence of venous thromboembolism in patients with cancer\u2014A cohort study using linked united Kingdom databases. Eur J Cancer 49:1404\u20131413","journal-title":"Eur J Cancer"},{"key":"4826_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1684\/hma.2010.0412","volume":"16","author":"DM Smadja","year":"2010","unstructured":"Smadja DM, Helley D, Gaussem P (2010) Angiogen\u00e8se, traitement h\u00e9parinique et pathologies canc\u00e9reuses. H\u00e9matologie 16:129\u2013142","journal-title":"H\u00e9matologie"},{"key":"4826_CR17","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3389\/fimmu.2019.01805","volume":"10","author":"AL Palacios-Acedo","year":"2019","unstructured":"Palacios-Acedo AL, M\u00e8ge D, Crescence L, Dignat-George F, Dubois C et al (2019) Platelets, Thrombo-Inflammation, and cancer: collaborating with the enemy. Front Immunol 10:1805","journal-title":"Front Immunol"},{"key":"4826_CR18","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, Quehenberger P, Zielinski C, Pabinger I (2010) Prediction of venous thromboembolism in cancer patients. Blood 116:5377\u20135382","journal-title":"Blood"},{"key":"4826_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","volume":"7","author":"M Verso","year":"2012","unstructured":"Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R (2012) A modified Khorana risk assessment score for venous throm-boembolism in cancer patients receiving chemotherapy: the protecht score. Intern Emerg Med 7:291\u2013292","journal-title":"Intern Emerg Med"},{"key":"4826_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","volume":"126","author":"ML Louzada","year":"2012","unstructured":"Louzada ML, Carrier M, Lazo-Langner A, Dao V, Kovacs MJ, Ramsay TO, Rodger MA, Zhang J, Lee AY, Meyer G et al (2012) Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Circulation 126:448\u2013454","journal-title":"Circulation"},{"key":"4826_CR21","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1111\/jth.15503","volume":"19","author":"NAM Guman","year":"2021","unstructured":"Guman NAM, van Geffen RJ, Mulder FI, van Haaps TF, Hovsepjan V et al (2021) Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer. J Thromb Haemost 19:2974\u20132983","journal-title":"J Thromb Haemost"},{"key":"4826_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","volume":"22","author":"GT Gerotziafas","year":"2017","unstructured":"Gerotziafas GT, Taher A, Abdel-Razeq H, AboElnazar E, Spyropoulos AC, COMPASS\u2013CAT Working Group et al (2017) A predictive score for thrombosis associated with Breast, Colorectal, Lung, or ovarian cancer: the prospective COMPASS-Cancer-Associated thrombosis study. Oncologist 22:1222\u20131231","journal-title":"Oncologist"},{"key":"4826_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12032-018-1120-9","volume":"35","author":"J Rupa-Matysek","year":"2018","unstructured":"Rupa-Matysek J, Lembicz M, Rogowska EK, Gil L, Komarnicki M et al (2018) Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients. Med Oncol 35:63","journal-title":"Med Oncol"},{"key":"4826_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38:496\u2013520","journal-title":"J Clin Oncol"},{"key":"4826_CR25","unstructured":"AFSOS. Prise en charge de la maladie thromboembolique veineuse en canc\u00e9rologie (2021) available from https:\/\/www.afsos.org"},{"key":"4826_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1055\/s-0039-1688497","volume":"45","author":"M alsh","year":"2019","unstructured":"alsh M, Moore EE, Moore H, Thomas S, Lune SV, Zimmer D, Dynako J, Hake D, Crowell Z, McCauley R et al (2019) Use of viscoelastography in Malignancy-Associated coagulopathy and thrombosis: A review. Semin Thromb Hemost 45:354\u2013372","journal-title":"Semin Thromb Hemost"},{"key":"4826_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MBC.0b013e328338dbe8","volume":"21","author":"G Lippi","year":"2010","unstructured":"Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ (2010) Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis 21:459\u2013463","journal-title":"Blood Coagul Fibrinolysis"},{"key":"4826_CR28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0049-3848(10)00227-6","volume":"125","author":"GC Connolly","year":"2010","unstructured":"Connolly GC, Khorana AA (2010) Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thromb Res 125:S1\u2013S7","journal-title":"Thromb Res"},{"key":"4826_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1538-7836.2009.03680.x","volume":"8","author":"R Simanek","year":"2010","unstructured":"Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, Schwarzinger I, Steger G, Jaeger U, Zielinski C, Pabinger I (2010) High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna cancer and thrombosis study (CATS). J Thromb Haemost 8:114\u2013120","journal-title":"J Thromb Haemost"},{"key":"4826_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/IJGM.S385772","volume":"16","author":"DB Akindo","year":"2023","unstructured":"Akindo DB, Ajayi OI (2023) Thrombotic pathogenesis and laboratory diagnosis in cancer patients, an update. Int J Gen Med 16:259\u2013272","journal-title":"Int J Gen Med"},{"key":"4826_CR31","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","volume":"27","author":"C Ay","year":"2009","unstructured":"Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AI, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I (2009) D-dimer and prothrombin fragment 1,2 predict venous thromboembolism in patients with cancer: results from Vienna cancer and thrombosis study. J Clin Oncol 27:4124\u20134129","journal-title":"J Clin Oncol"},{"key":"4826_CR32","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/1097-0142(19920615)69:12<2884::AID-CNCR2820691204>3.0.CO;2-S","volume":"69","author":"A Andr\u00e9n-Sandberg","year":"1992","unstructured":"Andr\u00e9n-Sandberg A, Lecander I, Martinsson G, Astedt B (1992) Peaks in plasma plasminogen activator inhibitor-1 concentration May explain thrombotic events in cases of pancreatic carcinoma. Cancer 69:2884\u20132887","journal-title":"Cancer"},{"key":"4826_CR33","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1158\/1078-0432.CCR-03-0198","volume":"10","author":"FL Sciacca","year":"2004","unstructured":"Sciacca FL, Ciusani E, Silvani A, Corsini E, Frigerio S, Pogliani S, Parati E, Croci D, Boiardi A, Salmaggi A (2004) Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin Cancer Res 10:1312\u20131317","journal-title":"Clin Cancer Res"},{"key":"4826_CR34","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/CORR.0000000000001832","volume":"479","author":"AG Tsantes","year":"2021","unstructured":"Tsantes AG, Papadopoulos DV, Trikoupis IG, Tsante KA, Mavrogenis AF, Koulouvaris P, Piovani D, Kriebardis AG, Gial-eraki A, Nikolopoulos GK et al (2021) Rotational thromboelastometry findings are associated with symptomatic venous thromboembolic complications after hip fracture surgery. Clin Orthop Relat Res 479:2457\u20132467","journal-title":"Clin Orthop Relat Res"},{"key":"4826_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3324\/haematol.2022.281315","volume":"108","author":"I Karampinis","year":"2023","unstructured":"Karampinis I, Nowak K, Koett J, Mess C, Wagner L, Gaiser T, Mayer FT, Goertz L, Schneider SW, Bauer AT (2023) Von Willebrand factor in the plasma and in the tumor tissue predicts cancer-associated thrombosis and mortality. Haematologica 108:261\u2013266","journal-title":"Haematologica"},{"key":"4826_CR36","doi-asserted-by":"crossref","unstructured":"TSANTES, Andreas G, Eleni PETROU, Konstantina TSANTE et al (2024) A.,. Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. Cancers, vol. 16, no 11, p. 2082","DOI":"10.3390\/cancers16112082"},{"key":"4826_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jth.13942","volume":"16","author":"NC Chan","year":"2018","unstructured":"Chan NC, Gross PL, Weitz JI (2018) Addressing the burden of Hospital-Related venous thromboembolism: the role of extended anticoagulant prophylaxis. J Thromb Haemost 16:413\u2013417","journal-title":"J Thromb Haemost"},{"key":"4826_CR38","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge D, Frere C, Connors JM, Khorana AA, Kakkar A et al (2022) International initiative on thrombosis and cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol 23:e334\u2013e347","journal-title":"Lancet Oncol"},{"key":"4826_CR39","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK et al (2021) American society of hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5:927\u2013974","journal-title":"Blood Adv"},{"key":"4826_CR40","doi-asserted-by":"publisher","first-page":"e746","DOI":"10.1016\/S2352-3026(20)30293-3","volume":"7","author":"HJ Sch\u00fcnemann","year":"2020","unstructured":"Sch\u00fcnemann HJ, Ventresca M, Crowther M, Briel M, Zhou Q et al (2020) Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis. Lancet Haematol 7:e746\u2013e755","journal-title":"Lancet Haematol"},{"key":"4826_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1814468","volume":"380","author":"M Carrier","year":"2019","unstructured":"Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S et al (2019) AVERT Investigators. Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med 380:711\u2013719","journal-title":"N Engl J Med"},{"key":"4826_CR42","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1056\/NEJMoa1814630","volume":"380","author":"AA Khorana","year":"2019","unstructured":"Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H et al (2019) CASSINI Investigators. Rivaroxaban for thromboprophylaxis in High- risk ambulatory patients with cancer. N Engl J Med 380:720\u2013728","journal-title":"N Engl J Med"},{"key":"4826_CR43","doi-asserted-by":"crossref","unstructured":"Mulder FI, Bosch FTM, van Es N (2020) Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand? Cancers (Basel). ; 12: 367","DOI":"10.3390\/cancers12020367"},{"issue":"5","key":"4826_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A FALANGA","year":"2023","unstructured":"FALANGA A, DI AYC, NISIO M et al (2023) Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Ann Oncol 34(5):452\u2013467","journal-title":"Ann Oncol"},{"issue":"16","key":"4826_CR45","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.23.00294","volume":"41","author":"KEYNSKHORANA Alok","year":"2023","unstructured":"Alok KEYNSKHORANA, Nicole AKUDERER (2023) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. J Clin Oncol 41(16):3063\u20133071","journal-title":"J Clin Oncol"},{"issue":"2","key":"4826_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3949\/ccjm.91a.23017","volume":"91","author":"HM Dave","year":"2024","unstructured":"Dave HM, Khorana AA (2024) Management of venous thromboembolism in patients with active cancer. Cleve Clin J Med 91(2):109\u2013117","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"4826_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.00","volume":"3","author":"L Gervaso","year":"2021","unstructured":"Gervaso L, Dave H, Khorana AA (2021) Venous and arterial thromboembolism in patients with cancer: JACC: cardiooncology state-of-the-art review. JACC CardioOncol 3(2):173\u2013190. https:\/\/doi.org\/10.1016\/j.jaccao.2021.03.00","journal-title":"JACC CardioOncol"},{"issue":"7","key":"4826_CR48","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1055\/s-0040-1712098","volume":"120","author":"M Giustozzi","year":"2020","unstructured":"Giustozzi M, Agnelli G, Del Toro-Cervera J et al (2020) Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis. Thromb Haemost 120(7):1128\u20131136. https:\/\/doi.org\/10.1055\/s-0040-1712098","journal-title":"Thromb Haemost"},{"issue":"11","key":"4826_CR49","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jacc.2019.01.017","volume":"73","author":"RC Mosarla","year":"2019","unstructured":"Mosarla RC, Vaduganathan M, Qamar A, Moslehi J, Piazza G, Giugliano RP (2019) Anticoagulation strategies in patients with cancer: JACC review topic of the week. J Am Coll Cardiol 73(11):1336\u20131349. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.017","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"4826_CR50","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","volume":"36","author":"AM Young","year":"2018","unstructured":"Young AM, Marshall A, Thirlwall J et al (2018) Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol 36(20):2017\u20132023. https:\/\/doi.org\/10.1200\/JCO.2018.78.8034","journal-title":"J Clin Oncol"},{"issue":"6","key":"4826_CR51","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/jth.14015","volume":"16","author":"BT Samuelson Bannow","year":"2018","unstructured":"Samuelson Bannow BT, Lee A, Khorana AA et al (2018) Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost 16(6):1246\u20131249. https:\/\/doi.org\/10.1111\/jth.14015","journal-title":"J Thromb Haemost"},{"issue":"7","key":"4826_CR52","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/oncolo\/oyad116","volume":"28","author":"TF Wang","year":"2023","unstructured":"Wang TF, Khorana AA, Agnelli G et al (2023) Treatment of cancer-associated thrombosis: recent advances, unmet needs, and future direction. Oncologist 28(7):555\u2013564","journal-title":"Oncologist"},{"key":"4826_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.6004\/jnccn.2024.0046","volume":"22","author":"MB STREIFF","year":"2024","unstructured":"STREIFF MB (2024) Cancer-Associated venous thromboembolic Disease, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22:483\u2013506","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"4826_CR54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/j.1875-9114.1998.tb03129.x","volume":"18","author":"DF Brophy","year":"1998","unstructured":"Brophy DF, Ford SL, Crouch MA (1998) Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy 18(3):646\u2013649","journal-title":"Pharmacotherapy"},{"key":"4826_CR55","unstructured":"Hakeam A, Hakeam Nasser Al-Sanea effect of major Gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)"},{"issue":"2","key":"4826_CR56","first-page":"212","volume":"110","author":"GIRARD MALKA, David","year":"2022","unstructured":"MALKA, David GIRARD, Nicolas SMADJA, David M et al (2022) Prophylaxis and management of cancer-associated thrombosis: practical issues about anticoagulant use. Bull Cancer 110(2):212\u2013224","journal-title":"Bull Cancer"},{"key":"4826_CR57","unstructured":"Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C et al Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)"},{"key":"4826_CR58","unstructured":"Posch F, Konigsbrugge O, Zielinski C, Pabinger I C. Ay;Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants"},{"key":"4826_CR59","unstructured":"Lanting VR, Bosch FTM, Marshall A, Raskob GE, Young A, Lee AYY et al Prediction of on treatment recurrent venous thromboembolism in patients with cancer: an individual patient data meta-analysis of randomized controlled trials"},{"key":"4826_CR60","unstructured":"Ihaddadene R, Le Gal G, Delluc A M. Carrier;Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis"},{"key":"4826_CR61","unstructured":"Carrier M, Le Gal G, Cho R, Tierney S, Rodger M A.Y. Lee;Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients"},{"issue":"3","key":"4826_CR62","first-page":"225","volume":"43","author":"S Narouze","year":"2018","unstructured":"Narouze S, Benzon HT, Provenzano D, Buvanendran A, De Andres J, Deer T, Rauck R, Huntoon MA (2018) Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (Second Edition): guidelines from the American society of regional anesthesia and pain Medicine, the European society of regional anaesthesia and pain therapy. Reg Anesth Pain Med 43(3):225\u2013262the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain","journal-title":"Reg Anesth Pain Med"},{"issue":"16","key":"4826_CR63","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidb\u00fcchel H, ESC Scientific Document Group (2018) The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330\u20131393","journal-title":"Eur Heart J"},{"issue":"2","key":"4826_CR64","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1053\/j.jvca.2018.07.023","volume":"33","author":"M Fabbro","year":"2019","unstructured":"Fabbro M, Dunn S, Rodriguez-Blanco YF, Jain P (2019) A narrative review for perioperative physicians of the 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants. J Cardiothorac Vasc Anesth 33(2):290\u2013301","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"4826_CR65","unstructured":"Li X 1, Li R 2, Wengen Zhu 2, Dexi Wu 2,Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis"},{"key":"4826_CR66","unstructured":"Rahman S, Trias J, Barouqa M et al Safety of Direct Acting Oral Anticoagulants (DOACs) in Comparison to Enoxaparin in Gastrointestinal and Genito-Urinary Cancers. Available at SSRN 4187027"},{"key":"4826_CR67","unstructured":"Shafia Rahman J, Trias M, Barouqa M, Kushnir, Henny H Billettc, safety of direct acting oral anticoagulants (DOACs) in comparison to Enoxaparin in Gastrointestinal and Genito-Urinary cancers"},{"key":"4826_CR68","unstructured":"Walaa A, Alshahrani RS, Alshahrani MA, Alkathiri, Saeed M, Alay, Abdulrahman M, Alabkka SA, Alaraj, Majed S, Al Yami, Waad A, Altayyar, Osamah M, Alfayez, Manar S, Basoodan AR, Almutairi Omar A Almohammed, safety and effectiveness of direct oral anticoagulants versus warfarin in patients with venous thromboembolism using Real-World data: A Systematic Review and Meta-Analysis"},{"key":"4826_CR69","unstructured":"Zygimantas Zaboras Camilla T\u00f8vik J\u00f8rgensen, Stensvold A, Heidi Hassel Pettersen, Aleksandra Galovic Grdinic, sigrid Kufaas Br\u00e6kkan, Waleed Ghanima, Mazdak Tavoly,Real-world data on treatment patterns and bleeding in Cancer-associated thrombosis: Data from the TROLL Registry"},{"key":"4826_CR70","unstructured":"Yutaka Ogino TI, Minamimoto Y, Kimura Y, Akiyama E, Okada K, Matsuzawa Y, Maejima N, Iwahashi N, Hibi K Masami Kosuge, Toshiaki Ebina, Toshiyuki Ishikawa, Kouichi Tamura, Kazuo Kimura, Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice"},{"key":"4826_CR71","unstructured":"Dimitrios, Farmakis Pavlos Papakotoulas,Eleni Angelopoulou, Theodoros Bischiniotis, George Giannakoulas, Panagiotis Kliridis, Dimitrios Richter, Ioannis Paraskevaidis, Anticoagulation for atrial fibrillation in cancer patients(review)"},{"key":"4826_CR72","unstructured":"Andrew B, Song RP, Rosovsky JM, Connors Hanny Al-Samkari, direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients"},{"key":"4826_CR73","unstructured":"\u00c9rique Jos\u00e9 F Peixoto de Miranda; Thamy Takahashi, Pharm B., Felipe Iwamoto, Pharm B., Suzete Yamashiro, Eliana Samano, Ariane Vieira Scarlatelli Macedo ; Eduardo Ramacciotti,Drug\u2013Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms"},{"key":"4826_CR74","unstructured":"https:\/\/en.wikipedia.org\/wiki\/Low-molecular-weight_heparin"},{"key":"4826_CR75","unstructured":"https:\/\/www.reddit.com\/r\/ausjdocs\/comments\/1aw1lzi\/confused_about_switching_tofrom_warfarin_clexane"},{"key":"4826_CR76","unstructured":"Elias John Elenjickal, Travlos CK, Marques P Thomas A Mavrakanas,Anticoagulation in Patients with Chronic Kidney Disease"},{"key":"4826_CR77","unstructured":"Siavash, Piran Sam Schulman,Treatment of bleeding complications in patients on anticoagulant therapy"},{"key":"4826_CR78","unstructured":"Kim S-A Ho-Young Yhim, Soo-Mee Bang, current management of Cancer-associated venous thromboembolism: Focus on Direct Oral Anticoagulants"},{"key":"4826_CR79","unstructured":"Katarzyna Rygiel Balancing risk of thromboembolism and bleeding in patients with cancer: Selecting Anticoagulant Therapy Based on Recent Clinical Trials"},{"key":"4826_CR80","unstructured":"Chen A, Stecker E, Warden BA Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges"},{"key":"4826_CR81","unstructured":"Bonadies N, Studt J-D, Parmentier S Dimitrios A. Tsakiris,Direct Oral Anticoagulants in Cancer Patients"},{"key":"4826_CR82","unstructured":"Dominique Farge Corinne Frere, Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges"},{"key":"4826_CR83","unstructured":"Karim Said,Hokusai-VTE Edoxaban for the treatment of venous thromboembolism"},{"key":"4826_CR84","unstructured":"https:\/\/ 52in52.goodybedside.georgetown.domains\/heme-onc\/caravaggio"},{"key":"4826_CR85","unstructured":"Carrier M, Abou-Nassar K, Mallick R et al AVERT: Apixaban to Prevent Venous Thromboembolism in Patients with Cancer"},{"key":"4826_CR86","unstructured":"www.reddit.com\/r\/multiplemyeloma\/comments\/1c9vk5x\/eliquis_apixaban_usage_for_prevention_of_vte"},{"key":"4826_CR87","unstructured":"Jordan K, Schaefer M, Li Z, Wu T, Basu MP, Dorsch GD, Barnes M, Carrier Jennifer J Griggs, Suman L Sood, Anticoagulant medication adherence for cancer-associated thrombosis: A comparison of LMWH to DOACs"},{"key":"4826_CR88","unstructured":"Aya F, Ozaki AS, Choi, Quan T, Le, Dennis T, Ko JK, Han SS, Park Cynthia A Jackevicius,Real-World adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: A Systematic Review and Meta-Analysis"},{"key":"4826_CR89","unstructured":"Ryan T, Borne MP, Turakhia PD, Varosy CA, Jackevicius LN, Marzec FA, Masoudi PL, Hess, Thomas M, Maddox & P. Michael Ho, adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation:findings from the veterans health administration"},{"key":"4826_CR90","unstructured":"Marc Carrier MD, Alejandro LazoLangner S, Shivakumar V, Tagalakis R, Zarychanski S, Solymoss N, Routhier J, Douketis K, Danovitch AY, Lee GL, Gal PS, Wells DJ, Corsi Timothy Ramsay, Doug Coyle, Isabelle Chagnon, Zahra Kassam, hardy Tao, and Marc A. Rodger,Screening for Occult Cancer in Unprovoked Venous Thromboembolism"},{"key":"4826_CR91","unstructured":"Alaa Shahbar A, Noor,Alqassem Y, Hakami,Abdulfattah Y Alhazmi,Bassim Albeirouti,Raghad Althubaiti,Khalid O. Alolasi,Mohammed Almazmumi,Faisal, Alhamdan,Rawan A A. Albariqi and Mohammed Alnuhait, Venous Thromboembolism in Cancer: Predictors of Recurrence and Bleeding in Patients on Direct Oral Anticoagulants"},{"key":"4826_CR92","unstructured":"Singh G, Rathi, Singh, Sharma D,Venous thromboembolism in cancer patients \u2013 magnitude of problem, approach, and management"},{"key":"4826_CR93","unstructured":"Eoin Donnellan, Alok A, Khorana Cancer and Venous Thromboembolic Disease"},{"key":"4826_CR94","unstructured":"Bao Y, Gao B, Yan P, Tian L & K. Yang,The effectiveness and safety if thromboprophylaxis in cancer patients based on Khorona score:a meta-analysis and systemic review of randomized controlled trials"},{"key":"4826_CR95","unstructured":"Hikmat A-R, Sharaf B, Al-Jaghbeer MJ, Abu-Fares H, Bater R Moataz Abu Shaer, Hala Abu-Jaish, Dima Abu Laban, Osama Salamah, Faris Tamimi, Khalid Ashouri, Tareq Salameh, Raed Zughul, Yazan Alhalaseh,COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and\/or immunotherapy, the CK-RAM study"},{"key":"4826_CR96","unstructured":"Casey OC, Escalante CP, Goldhaber SZ, Robert McBane JM, Connors GE Raskob,Treatment of Cancer-Associated venous thromboembolism with Low-Molecular-Weight heparin or direct oral anticoagulants: Patient Selection, Controversies, and Caveats"},{"key":"4826_CR97","unstructured":"Randy K, Ramcharitar L, Man MS, Khaja Merry Ellen Barnett, Aditya Sharma, A review of the past, Present and Future of Cancer-associated Thrombosis Management"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-025-04826-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:07:43Z","timestamp":1761908863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-025-04826-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4826"],"URL":"https:\/\/doi.org\/10.1007\/s00280-025-04826-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"104"}}